Carl Zeiss Meditec (ETR:AFX) has been given a €60.00 ($74.07) price target by research analysts at Nord/LB in a research note issued to investors on Monday. The firm presently has a “buy” rating on the stock. Nord/LB’s price objective indicates a potential upside of 20.58% from the stock’s previous close.
Several other brokerages have also issued reports on AFX. Berenberg Bank set a €55.00 ($67.90) price objective on Carl Zeiss Meditec and gave the stock a “neutral” rating in a report on Friday, January 12th. Deutsche Bank set a €48.00 ($59.26) target price on Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Thursday, December 14th. Independent Research set a €54.00 ($66.67) target price on Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Friday, December 8th. Commerzbank set a €42.00 ($51.85) target price on Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Friday, December 8th. Finally, Kepler Capital Markets set a €48.50 ($59.88) target price on Carl Zeiss Meditec and gave the company a “neutral” rating in a report on Monday. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of €52.75 ($65.12).
Shares of Carl Zeiss Meditec (AFX) traded up €0.38 ($0.47) during trading hours on Monday, hitting €49.76 ($61.43). The company had a trading volume of 115,700 shares, compared to its average volume of 93,147. Carl Zeiss Meditec has a twelve month low of €36.56 ($45.14) and a twelve month high of €55.25 ($68.21). The stock has a market capitalization of $4,450.00 and a price-to-earnings ratio of 31.69.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.